Blinatumomab Intravenous and Insulin glargine
Determining the interaction of Blinatumomab Intravenous and Insulin glargine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: blinatumomab
Brand name: Blincyto
Synonyms: Blinatumomab
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Blinatumomab Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Blinatumomab Intravenous-Insulin Glargine (U-100) Vials
- Blinatumomab Intravenous-Insulin Glargine (U-300) Pens
- Blinatumomab Intravenous-Insulin glargine and lixisenatide
- Blinatumomab Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Blinatumomab Intravenous-Insulin glargine, recombinant Subcutaneous
- Insulin glargine-Blincyto
- Insulin glargine-Blisovi 24 Fe
- Insulin glargine-Blisovi 24 FE birth control
- Insulin glargine-Blisovi Fe 1.5/30
- Insulin glargine-Blisovi Fe 1/20
- Insulin glargine-Blocadren